Condition
Cystic Fibrosis, Pulmonary
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Active Not Recruiting1
Completed1
Recruiting1
Not Yet Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04375514Phase 1TerminatedPrimary
Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis
NCT06339450Not ApplicableNot Yet RecruitingPrimary
Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects
NCT06084468Active Not Recruiting
Cardiac Structure and Function in Patients with Cystic Fibrosis
NCT05604495RecruitingPrimary
Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis
NCT03437811CompletedPrimary
Airway Clearance System (K031876) Phase IV Device Efficacy
Showing all 5 trials